Investigational New Drugs 1991-11-01

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

B G Durie, J Crowley, C A Coltman, R A Chapman, S P Balcerzk, J D Bonnet, D A Lipschitz, R L Stephens, B D Cheson

文献索引：Invest. New Drugs 9(4) , 329-31, (1991)

全文：HTML全文

摘要